Green-synthesized silver nanoparticles optimized by Taguchi method inhibit urease activity in antibiotic-resistant helicobacter pylori Authors: Reza Ghanbari, Alireza Yazdinezhad, Hossein Danafar, Shayan Asadi, Hafezeh Salehabadi Published: 2026 ABSTRACT AbstractHelicobacter pylori (H. pylori) infection remains a significant global health challenge, contributing to various gastrointestinal disorders, including peptic ulcers and gastric cancer. The bacterium’s urease enzyme plays a pivotal role in its survival by neutralizing gastric acidity, making urease inhibitors a promising therapeutic strategy. This study explores the green synthesis of silver nanoparticles (AgNPs) using Persian lime (Citrus latifolia T.) fruit extract as a reducing and stabilizing agent, optimized via the Taguchi method to achieve minimal particle size for enhanced bioactivity. Characterization techniques such as Fourier-transform infrared spectroscopy (FT-IR), dynamic light scattering (DLS), transmission electron microscopy (TEM), X-ray diffraction (XRD), and UV-Vis spectroscopy confirmed the formation of spherical AgNPs with an average size of 27.63 nm and a zeta potential of -13.8 mV, indicating good stability. The green synthesized AgNPs exhibited potent urease inhibitory activity, with an IC50 value of 15.02 ± 2.36 µg/mL, surpassing that of Persian lime (Citrus latifolia) fruit extract (IC50= 33.31 ± 1.43 µg/mL). In contrast, chemically synthesized AgNPs counterparts exhibited minimal inhibitory activity against urease. These findings highlight the potential of green synthesized AgNPs as effective urease inhibitors with possible relevance to H. pylori-associated pathogenesis. Since H. pylori urease is structurally homologous to the jack bean urease used in this study, these results warrant further investigation using direct anti-H. pylori assays and in vivo models. The integration of natural extracts in nanotechnology not only reduces environmental impact but also enhances biocompatibility, paving the way for novel antimicrobial therapies. Consistently refer to Sample 7 conditions (pH 5, 3500 µL, 5 mM, 80 °C) as the experimentally validated optimum, while noting the Taguchi-predicted conditions where appropriate.Keywords: Helicobacter pylori, Silver Nanoparticles, Urease Inhibition, Green Synthesis, Taguchi Optimization, Persian Lime ExtractSubject terms: Biochemistry, Biological techniques, Biotechnology, Chemistry, Drug discovery, Microbiology, Nanoscience and technology Introduction Helicobacter pylori (H. pylori), a spiral-shaped Gram-negative bacterium, is recognized as one of the most prevalent human pathogens, infecting approximately half of the world’s population1,2. Discovered in 1982 by Barry Marshall and Robin Warren, who were awarded the Nobel Prize in Physiology or Medicine in 2005 for their groundbreaking work, H. pylori colonizes the gastric mucosa and is a primary etiological agent in peptic ulcer disease, chronic gastritis, and gastric adenocarcinoma3. The bacterium’s ability to thrive in the harshly acidic environment of the stomach is largely attributed to its urease enzyme, which hydrolyzes urea to produce ammonia and carbon dioxide, thereby creating a neutral microenvironment that facilitates survival and pathogenesis. This enzyme allows H. pylori to withstand pH levels as low as 2.0, a feat that few microorganisms can achieve4,5. Urease (EC 3.5.1.5) is a nickel-dependent metalloenzyme that catalyzes the hydrolysis of urea into ammonia and carbamate, which spontaneously decomposes to carbon dioxide and another ammonia molecule6. This reaction is crucial for H. pylori, as the generated ammonia buffers the periplasmic pH, protecting the bacterium from gastric acid7. Inhibition of urease activity disrupts this protective mechanism, rendering the bacterium vulnerable to the host’s acidic environment and immune responses8,9. Traditional urease inhibitors, such as hydroxamic acids and phosphorodiamidates, have shown promise but often suffer from toxicity, poor bioavailability, and limited efficacy in vivo. For instance, acetohydroxamic acid, an FDA-approved inhibitor, has side effects like hemolytic anemia, limiting its use10,11. Given the indispensable role of urease in H. pylori acid acclimatization and the well-documented limitations of conventional urease inhibitors, there is an urgent need for novel, biocompatible urease-targeting agents with improved efficacy and reduced toxicity. In recent years, nanotechnology has emerged as a transformative approach in antimicrobial therapy12,13. Silver nanoparticles (AgNPs), in particular, exhibit broad-spectrum antibacterial properties due to their high surface area-to-volume ratio, which enhances interaction with microbial cells14,15. Among various metallic nanoparticles investigated for biomedical applications, AgNPs were selected for this study due to their unique combination of broad-spectrum antimicrobial activity, multi-mechanistic action (membrane disruption, ROS generation, and enzyme inhibition), and demonstrated capacity for urease inhibition through active-site nickel chelation and conformational disruption16. Furthermore, unlike other nanomaterials such as gold, zinc oxide, or copper nanoparticles, AgNPs offer a well-established safety profile at therapeutic concentrations and are particularly amenable to green synthesis using plant extracts, which enhances their biocompatibility and enzymatic inhibition potential17. AgNPs can disrupt bacterial membranes, generate reactive oxygen species (ROS), and inhibit enzyme activity, including urease16,18. The multi-modal action of AgNPs reduces the likelihood of resistance development19. However, conventional chemical synthesis methods for AgNPs often involve toxic reducing agents like sodium borohydride, posing environmental and health risks20. These methods can produce byproducts that contaminate the final product, making them unsuitable for biomedical applications21,22. Green synthesis, utilizing plant extracts as bioreductants, offers a sustainable alternative, leveraging natural compounds such as polyphenols, flavonoids, and terpenoids for reduction and stabilization23–25. This method is cost-effective, scalable, and environmentally friendly, aligning with the principles of green chemistry17. Numerous plants have been used, but citrus species are particularly effective due to their high content of reducing agents26. Persian lime (Citrus latifolia), known locally as Shiraz limoo, is rich in bioactive compounds, including citric acid, ascorbic acid, and flavonoids, which can serve as effective reducing and capping agents for AgNP synthesis27. Citric acid, comprising 5–8% of the fruit, acts as a weak reducer, while flavonoids like hesperidin provide antioxidant properties28. This study aims to synthesize AgNPs using Persian lime crude extract via a green method, optimize synthesis parameters using the Taguchi orthogonal array design to minimize particle size, and evaluate their urease inhibitory potential29. By comparing green-synthesized AgNPs with chemically produced ones, we seek to demonstrate the superiority of eco-friendly approaches in terms of particle characteristics and bioactivity30. Although green synthesis of AgNPs using various citrus extracts such as Citrus limon zest and mixed citrus peels has been reported31,32, and Taguchi optimization has been applied to plant-mediated nanoparticle synthesis from other botanical sources33,34, to the best of our knowledge, no study has combined Citrus latifolia crude extract-mediated green synthesis with Taguchi optimization specifically targeting urease inhibition in antibiotic-resistant H. pylori. While green synthesis of AgNPs using various citrus extracts such as Citrus limon zest and mixed citrus peels has been reported35, and Taguchi optimization has been applied to plant-mediated nanoparticle synthesis from other botanical sources31, to the best of our knowledge, no study has combined Citrus latifolia crude extract-mediated green synthesis with Taguchi optimization specifically targeting urease inhibition in antibiotic-resistant H. pylori. The unique phytochemical profile of Persian lime—particularly its balanced content of citric acid (5–8%), ascorbic acid, and flavonoids such as hesperidin—provides a distinct reducing-capping system that may contribute to enhanced particle characteristics and bioactivity compared to other citrus-based syntheses25,36. The Taguchi method, a robust statistical tool for process optimization, minimizes variability and identifies optimal conditions with fewer experiments37,38. Developed by Genichi Taguchi in the 1950 s, it uses orthogonal arrays to test factor combinations efficiently39. Parameters such as pH, extract volume, extract concentration, and temperature were optimized to achieve the smallest AgNP size, as smaller particles typically exhibit enhanced antimicrobial efficacy due to increased surface reactivity. The “smaller is better” criterion was applied, with signal-to-noise ratio (S/N) calculating robustness against noise factors like environmental variations40,41. In this work, we present a comprehensive investigation into the green synthesis of AgNPs from Persian lime extract, optimized using Taguchi methodology, and their application as urease inhibitors. Through experimental characterization and computational modeling, we demonstrate the nanoparticles’ efficacy in disrupting H. pylori survival mechanisms, offering a novel, sustainable therapeutic avenue that integrates traditional herbal knowledge with modern nanotechnology. It should be noted that the present study focuses on evaluating the urease inhibitory activity of green synthesized AgNPs using jack bean urease (Canavalia ensiformis) as a model enzyme. While the rationale for this work is grounded in the critical role of urease in H. pylori survival, direct antibacterial assays against H. pylori strains were not performed and remain a subject for future investigation. Methods Materials All chemicals used were of analytical grade. Silver nitrate (AgNO3, ≥ 99.0%) was purchased from Sigma-Aldrich. Trisodium citrate dihydrate (Na3C6H5O7·2H2O, ≥ 99.0%) served as the reducing agent for chemical synthesis. Persian lime (Citrus latifolia) was sourced from local markets and identified by herbarium of the Department of Pharmacognosy, Faculty of Pharmacy, Zanjan University of medical sciences (Voucher number:31552). Sodium hydroxide (NaOH) and nitric acid (HNO3) were used for pH adjustment. Jack bean urease (Type IX, powder, 50,000–100,000 units/g solid) was obtained from Sigma-Aldrich for inhibition assays. Urea, phenol, sodium hypochlorite (NaOCl), and sodium nitroprusside were used in the Berthelot assay. Deionized water was used throughout the experiments. Preparation of Persian lime extract Dried Persian lime fruits were ground into a fine powder using a laboratory mill. Maceration was employed for extraction: 10 g of powder was mixed with 100 mL of deionized water (w/v ratio 1:10) and stirred at room temperature for 24 h. The mixture was filtered through Whatman No. 1 filter paper, and the filtrate was concentrated under reduced pressure using a rotary evaporator at 40 °C and freeze dried to obtain a viscous extract. To standardize the reducing capacity of the crude extract across Taguchi experiments, working concentrations were expressed as mM equivalents of total reducing capacity, calibrated against citric acid standards using the Folin-Ciocalteu assay. The stock extract was first assayed for total phenolic content (mg gallic acid equivalents per mL), then diluted to solutions with reducing equivalents of 1 mM, 3 mM, and 5 mM citric acid. This normalization ensures reproducible comparison across extract batches. All synthesis experiments used freshly prepared extract dilutions within 24 h of preparation. The extract was stored at 4 °C until use. This method was chosen for its simplicity and ability to extract bioactive compounds effectively, as supported by literature on citrus extractions. The resulting extract was analyzed for pH (approximately 3–4) and total solid content to ensure consistency across batches, with yields typically ranging from 20 to 25% based on dry weight. All synthesis experiments were performed in triplicate (n = 3) to ensure reproducibility. The optimized synthesis conditions were validated across three independent batches prepared over a two-week period. Chemical synthesis of AgNPs (Frens method) As shown in scheme 1, a modified Frens method was used. Briefly, 50 mL of 1 mM AgNO3 solution was heated to boiling under magnetic stirring. Then, 1 mL of 1% (w/v) trisodium citrate was added dropwise. The mixture was boiled for 15 min until a yellow color appeared, indicating AgNPs formation. The solution was cooled to room temperature and stored in the dark. This method is widely used for its control over particle size through citrate concentration. To purify, the solution was centrifuged at 14,000 rpm for 15 min to separate nanoparticles from excess reagents. The supernatant was discarded, and the pellet was resuspended in deionized water to form a stable colloidal suspension. The final concentration was adjusted to approximately 0.1 mM for consistency with green-synthesized samples, and pH was monitored to remain around 7. Schematic representation of chemical synthesis of AgNPs. Green synthesis of AgNPs For the green synthesis, a plant-mediated approach was employed using the prepared Persian lime extract as both reducing and stabilizing agent. For each of the nine experiments designed via Taguchi method (detailed in 2.5), 50 mL of 1 mM AgNO3 solution was placed in an Erlenmeyer flask on a heater stirrer and heated to the specified temperature (40 °C, 60 °C, or 80 °C). The pH was adjusted to the desired level (5, 7, or 9) using 0.1 M HNO3 or NaOH, monitored with a pH meter. Then, the specified volume (1.5 mL, 2.5 mL, or 3.5 mL) of extract at the designated concentration (1 mM, 3 mM, or 5 mM) was added dropwise under constant stirring. Formation of AgNPs was indicated by a color change from colorless to yellow and then brown-amber. The reaction continued for an additional 40 min at the same temperature with stirring to ensure completion. The colloidal solution was cooled and stored in dark containers in a refrigerator for further characterization. This method leverages the bioactive compounds in the extract, such as citric acid and flavonoids, for reduction, resulting in eco-friendly nanoparticles with enhanced stability due to natural capping. All urease inhibition assays were performed in triplicate, and IC₅₀ values were calculated from dose-response curves with error bars representing standard deviation. Taguchi optimization The Taguchi orthogonal array design (L9) was used to optimize synthesis parameters for minimal AgNP size, focusing on four factors at three levels each: temperature (40 °C, 60 °C, 80 °C), pH (5, 7, 9), extract concentration (1 mM, 3 mM, 5 mM), and extract volume (1.5 mL, 2.5 mL, 3.5 mL). The experimental matrix was generated using Minitab software. The ‘smaller is better’ quality characteristic was selected as the optimization criterion because smaller nanoparticles exhibit higher surface-to-volume ratios, leading to enhanced antimicrobial activity and improved urease inhibition potential. Each of the nine Taguchi runs was performed in triplicate, meaning three independent synthesis batches per condition (n = 3). Particle size was measured via DLS for each replicate batch. Mean particle size and standard deviation reported in Table 1 were calculated from the three independent batches. The optimal conditions were determined by analyzing main effects plots and ANOVA, identifying temperature as the most influential factor. This statistical approach minimized experimental runs while accounting for interactions and noise factors like environmental variations, ensuring scalable and reproducible synthesis. Table 1 represents the synthesis parameters. The Taguchi S/N analysis identified the theoretically optimal combination as pH 5, extract volume 2500 µL, concentration 5 mM, and temperature 80 °C (predicted size ~ 40.5 nm). As this combination was not among the L9 experimental runs, Sample 7 (pH 5, 3500 µL, 5 mM, 80 °C) — the best-performing run within the array with an actual size of 44.62 nm — was selected for all subsequent characterization and biological assays. Taguchi optimization was selected over Response Surface Methodology (RSM) due to its experimental efficiency (requiring fewer runs via orthogonal arrays), its focus on robustness through signal-to-noise ratio analysis, and its suitability for single-objective optimization of particle size. While RSM is advantageous for modeling complex response surfaces and interactions, our study prioritized identifying robust conditions with minimal experimental burden, making Taguchi the more appropriate choice. Table 1Synthesis parameter of different pH and volumes.ExperimentpHExtract Volume (µL)Extract Concentration (mM)Temperature (°C)Particle Size (nm)S/N Ratio151500140530−54.48252500360120−41.5835350058044.62−33.0047150038085−38.59572500540200−46.02673500160150−43.5279150056095−39.5589250018060−35.56993500340300−49.54 Synthesis parameter of different pH and volumes. Characterization of AgNPs The synthesized AgNPs were characterized using multiple advanced techniques to confirm their formation, size distribution, morphology, crystallinity, surface chemistry, and stability. Both green and chemical synthesized AgNPs were analyzed under identical conditions for comparative purposes. All characterizations were performed on the optimized green synthesized AgNPs (sample 7) and the chemical synthesized AgNPs (sample 10). Instruments used included those specified in the thesis for precision and reproducibility. FT-IR spectroscopy FT-IR spectra were recorded using a Bruker Tensor 27 spectrometer (Bruker, Germany) to identify the functional groups involved in the reduction and capping of AgNPs. Samples were prepared by mixing lyophilized AgNPs with potassium bromide (KBr) at a 1:100 ratio (sample: KBr), then pressed into transparent pellets under high pressure. The spectra were scanned in the range of 400 to 4000 cm⁻¹ with a resolution of 4 cm⁻¹, averaging 32 scans per sample to enhance signal-to-noise ratio. This method allows detection of vibrational modes such as O-H, C = O, and Ag-O stretches, confirming the role of bioactive compounds from the Persian lime extract. Background correction was applied using pure KBr pellets, and data analysis focused on peak shifts indicative of biomolecular interactions. Dynamic light scattering (DLS) Hydrodynamic diameter, polydispersity index (PDI), and zeta potential were determined using a Zetasizer Nano ZS (Malvern Instruments, UK) equipped with a He-Ne laser operating at 633 nm and a scattering angle of 173°. Samples were diluted 10-fold in deionized water to avoid multiple scattering effects, sonicated for 5 min to ensure dispersion, and measured at 25 °C in disposable cuvettes. Three replicate measurements were taken for each sample, with 10–15 sub-runs per measurement to achieve reliable autocorrelation functions. The PDI was calculated to assess size uniformity (values < 0.3 indicate monodispersity), and zeta potential was derived from electrophoretic mobility using the Helmholtz-Smoluchowski equation. This technique accounts for the hydration layer around particles, providing insights into colloidal stability in aqueous media. Transmission electron microscopy (TEM) Morphology, core size, and aggregation state were examined using a Philips EM208S transmission electron microscope operating at an accelerating voltage of 100 kV. Samples were prepared by diluting the AgNPs colloidal solution 20-fold in deionized water, ultrasonically dispersing for 10 min, and placing a 5–10 µL drop onto a carbon-coated copper grid (200 mesh). The grids were allowed to air-dry at room temperature overnight in a dust-free environment to prevent contamination. Images were captured at various magnifications (up to 200,000x) to visualize individual particles and clusters. Size distribution histograms were generated by measuring at least 100 particles using ImageJ software, yielding mean size and standard deviation. This high-resolution imaging complements DLS by providing dry-state morphology without hydration effects. X-ray diffraction (XRD) Crystallinity and phase purity were assessed using a Philips PW1730 X-ray diffractometer with Cu Kα radiation (λ = 1.5406 Å) generated at 40 kV and 30 mA. Lyophilized AgNPs powder was placed on a zero-background silicon holder, and scans were performed over a 2θ range of 10° to 80° at a step size of 0.02° and a scan rate of 2°/min. Peak positions were identified and compared to the JCPDS database (card no. 04–0783) for face-centered cubic silver. Crystallite size was calculated using the Scherrer equation: D = Kλ/(β cos θ), where D is crystallite size, K is the shape factor (0.9), λ is wavelength, β is full width at half maximum (FWHM) in radians, and θ is the Bragg angle. Debye-Scherrer analysis confirmed no impurity peaks, ensuring high purity. UV-vis spectroscopy Surface plasmon resonance (SPR) was confirmed using a Jenway 6300 UV-Vis spectrophotometer scanning from 300 to 700 nm with a 1 nm resolution and a scan speed of 200 nm/min. Samples were diluted in deionized water to an optical density < 1.0 and placed in quartz cuvettes with a 1 cm path length. The SPR peak position, intensity, and width were analyzed to infer particle size and uniformity—blue shifts indicating smaller sizes. Baseline correction was applied using deionized water, and spectra for all nine Taguchi samples plus the chemical control were recorded to monitor synthesis progress via color change from pale yellow to amber. This optical characterization validates nanoparticle formation non-destructively. Urease inhibition assay (Berthelot method) Urease activity was measured using the Berthelot colorimetric method. The reaction mixture contained 850 µL phosphate buffer (pH 7.4), 15 µL urea (100 mM), 135 µL AgNPs suspension (various concentrations: 3.125 to 100 µg/mL), and 50 µL urease (0.2 units/mL). After 30 min incubation at 37 °C, 500 µL phenol reagent (1% w/v phenol, 0.005% w/v sodium nitroprusside) and 500 µL alkaline reagent (0.5% w/v NaOH, 0.1% v/v NaOCl) were added. After 30 min, absorbance was measured at 630 nm. Inhibition percentage was calculated as I (%) = 100 - (T/C × 100), where T is test absorbance and C is control. IC50 was determined using GraphPad Prism software via dose-response curve fitting. Positive control used acetohydroxamic acid, blank omitted urease. All urease inhibition experiments were performed in triplicate (n = 3 independent assays), each consisting of a fresh reaction mixture prepared from the same AgNP stock suspension and enzyme batch to minimize inter-assay variability. Data are presented as mean ± SD. IC50 values were determined using GraphPad Prism by fitting inhibition data to a four-parameter logistic (4PL) nonlinear regression model that goodness of fit was evaluated by R2. All experiments were performed in triplicate (n = 3) and data are presented as mean ± SD. Statistical differences among groups were assessed by one-way ANOVA followed by Tukey’s HSD post-hoc test (p < 0.05). Results and discussion Characterization of optimized AgNPs The best-performing L9 run (Sample 7: pH 5, extract volume 3500 µL, concentration 5 mM, temperature 80 °C; actual size 44.62 nm) was selected for comprehensive characterization, as it yielded the smallest particle size among all experimental runs. The optimized synthesis conditions (Sample 5) demonstrated good reproducibility across three independent batches, with consistent UV-Vis SPR peak position (418 ± 3 nm), hydrodynamic diameter (44.64 ± 2.1 nm), PDI (0.212 ± 0.018), and urease inhibitory activity (IC₅₀ = 12.47 ± 1.3 µg/mL). Values represent mean ± standard deviation. FT-IR analysis The FT-IR spectra (Fig. 1) of the green synthesized AgNPs (AgNPs_Citrus) and chemical synthesized AgNPs (AgNPs_Chem) showed peaks at 3390 cm− 1 (O-H stretch), 1640 cm− 1 (C = O stretch), 1490 cm− 1 (C = C stretching), and 668 cm− 1 (Ag-O stretch). These signatures suggest the capping of nanoparticles by organic compounds, corroborating successful synthesis and stabilization. The observed bands indicate the involvement of hydroxyl and carbonyl functional groups in the reduction and capping processes. Specifically, the shift in the O–H stretching vibration from 3390 cm− 1 to 3340 cm− 1 suggests the oxidation of polyphenols, thereby confirming their direct role in reducing Ag+ ions to Ag0. Furthermore, compared to their chemically synthesized counterparts, the green AgNPs exhibited a broader O–H peak, which is attributed to the diverse hydroxyl groups present in the plant-derived phytochemicals. This characteristic likely contributes to the enhanced colloidal stability of the biogenic nanoparticles. Comparison of FT-IR spectra of silver nanoparticles synthesized by chemical (sample 10) and green (sample 7) methods. The presence of C-H stretch at 2080 cm− 1 in green synthesized AgNPs indicates alkyl groups from the extract. These functional groups not only reduce silver ions but also prevent aggregation through steric hindrance and electrostatic repulsion. Collectively, the observed spectral signatures and peak shifts are characteristic of key bioactive compounds in the Persian lime extract—such as flavonoids and citric acid—acting as dual-function agents for reduction and capping. This aligns with the mechanism where polyphenols donate electrons for Ag⁺ reduction while forming a stabilizing layer around the nanoparticles. Given the close similarity between the FT-IR spectra of the control and the nanocomposite for all other peaks, the stabilization of the AgNPs can be attributed specifically to the alcoholic (–OH) groups. The absence of new or shifted peaks suggests other functional groups do not play a major capping role. In comparison to other studies, similar FT-IR patterns have been reported in green AgNPs synthesized from ginger extracts, where O-H and C = O stretches confirmed the role of plant metabolites in nanoparticle formation. Another study using Cassia fistula flower extract showed comparable broader O-H peaks in green AgNPs versus sharper peaks in chemically synthesized ones, attributing the difference to diverse organic capping agents that enhance biocompatibility and reduce toxicity compared to uniform chemical stabilizers like citrate. These comparisons highlight the superiority of green methods in imparting multifunctional surface chemistry, potentially leading to better bioactivity without the environmental drawbacks of chemical synthesis42,43. DLS analysis DLS revealed a hydrodynamic diameter of 44.64 nm for green synthesized AgNPs (AgNPs_Citrus) with a polydispersity index (PDI) of 0.212, indicating monodispersity (Fig. 2). Zeta potential was − 13.8 mV, sufficient for electrostatic repulsion and stability. Chemical synthesized AgNPs (AgNPs_Chem) had a larger size (73.46 nm, PDI 0.241) and zeta potential (−31.6 mV), suggesting greater stability but larger aggregation potential due to citrate capping. The discrepancy between DLS and TEM sizes is expected, as DLS measures hydrodynamic radius including solvation layers, while TEM provides dry-state core size. The negative zeta potential in. Sizing (a) and charge (b) curves of chemical synthesized AgNPs (sample 10) and Sizing (c) and charge (d) of green synthesized AgNPs (sample 7) by DLS method. AgNPs_Citrus is due to carboxylate groups from citric acid in the extract, which ionize to COO−. Analysis of the DLS data underscores the advantage of green synthesis in producing smaller, more uniform nanoparticles, as evidenced by the lower PDI, which correlates with reduced aggregation and improved dispersibility in biological media. The moderate zeta potential, while lower than chemical counterparts, is adequate for stability due to additional steric hindrance from plant-derived caps. Comparative studies often report green AgNPs exhibiting smaller hydrodynamic sizes and comparable or superior stability to chemical ones; for instance, a study on green versus chemically synthesized AgNPs capped with glutathione found green variants had enhanced bioactivity and reduced cytotoxicity, with sizes around 40–50 nm similar to our findings44. In citrus-based green synthesis, such as using Citrus limon zest extract, DLS sizes of 30–60 nm with PDI < 0.3 were observed, reinforcing that plant extracts yield more monodisperse particles than chemical methods, potentially due to natural surfactants preventing coalescence. This comparison suggests our optimized green synthesized AgNPs offer better potential for biomedical applications where size uniformity enhances cellular uptake and activity45. Although the zeta potential of green-synthesized AgNPs (− 13.8 mV) is lower in absolute value than that of chemically synthesized AgNPs (− 31.6 mV), the colloidal stability of the former is maintained through a dual electrosteric mechanism combining electrostatic repulsion from ionized carboxylate groups (COO⁻) with steric hindrance provided by the phytochemical capping layer. This moderate surface charge may in fact be advantageous for biological applications, as it permits sufficient interaction with biological targets such as urease while preventing aggregation, as evidenced by the low PDI (0.212), small hydrodynamic size (44.64 nm), and sharp SPR peak (418 nm). The superior urease inhibitory activity of green AgNPs (IC50=15.02 ± 2.36 µg/mL) compared to chemical AgNPs (< 50% inhibition), despite the latter’s higher zeta potential, underscores that the nature of the capping layer and particle size are more critical determinants of biological efficacy than zeta potential magnitude alone. Zeta potential was − 13.8 mV, indicating moderate electrostatic repulsion. Colloidal stability is primarily attributed to steric hindrance from phytochemical capping (citric acid, flavonoids, polyphenols), consistent with the low PDI (0.212). TEM analysis Transmission Electron Microscopy (TEM) images of the green-synthesized AgNPs_Citrus (Fig. 3a) revealed predominantly spherical nanoparticles with minimal aggregation. The measured average particle size was 27.63 ± 10.35 nm (Fig. 3b). This represents a significant size reduction and a more uniform morphology compared to chemically synthesized AgNPs, which exhibited non-spherical shapes and a larger average size range of 59–69 nm 47. (a) TEM image of green synthesized silver nanoparticles (AgNPs_Citrus) showing spherical morphology, (b) Statistical results obtained from the size of silver nanoparticles synthesized by the green method. The organic coating from extract prevents clustering, enhancing biocompatibility. This size range is ideal for antimicrobial applications, allowing cellular penetration and enzyme interaction. The histogram shows a normal distribution, with most particles between 20 and 30 nm, consistent with green synthesis literature where plant extracts control growth. The TEM results provide direct visual evidence of the nanoparticles’ core morphology, confirming the effectiveness of the Persian lime extract in controlling size and shape through biomolecular templating. The minimal aggregation observed is likely due to the steric stabilization provided by flavonoids and other extract components. When compared to other studies, our average size of 27.63 nm is within the typical range for green AgNPs from citrus sources; for example, AgNPs synthesized from Citrus macroptera fruit peel exhibited spherical shapes with sizes of 20–40 nm and similar low aggregation. Biogenic AgNPs generally show less aggregation and better biocompatibility than chemical ones, as noted in a comparative analysis where green-synthesized particles had core sizes 10–30 nm versus larger, more clustered chemical AgNPs, leading to superior antimicrobial efficacy. These findings emphasize that green methods, like ours, produce nanoparticles optimized for therapeutic use against pathogens like H. pylori by facilitating better interaction with bacterial enzymes47,48. XRD analysis X-ray diffraction (XRD) analysis was performed at room temperature to determine the crystal structure, phase composition, and purity of the AgNPs_Citrus. XRD pattern (Fig. 4) displayed peaks at 2θ = 38.1°, 44.6°, 64.5°, and 77.5°, corresponding to (111), (200), (220), and (311) planes of face-centered cubic (fcc) silver (JCPDS 04–0783)46,49. XRD pattern of green synthesized silver nanoparticles (AgNPs_Citrus) confirming face-centered cubic structure. The XRD analysis confirms the successful synthesis of crystalline, phase-pure silver nanoparticles via the green method. The average crystallite size, determined using the Scherrer equation, was calculated to be 28.38 nm, which is consistent with the particle dimensions observed by TEM. No impurity peaks indicate high purity. The strong (111) peak suggests preferred orientation, common in green synthesized AgNPs. SPR at ~ 420 nm indicates nanoscale silver, while negative zeta potentials ensure colloidal stability via electrostatic repulsion50. TEM and XRD confirm crystallinity and morphology, essential for bioactivity51. The XRD analysis validates the crystalline purity and fcc structure of the AgNPs, with the crystallite size closely matching TEM measurements, indicating minimal polycrystallinity. The absence of impurities highlights the clean reduction process enabled by the extract. In comparison, similar XRD patterns with prominent (111) peaks have been observed in green AgNPs from Citrus sinensis peel extract, where crystallite sizes ranged from 20 to 30 nm, confirming the reliability of plant-mediated synthesis for producing high-purity nanoparticles. Studies comparing green and chemical methods often note that green AgNPs exhibit sharper peaks and better crystallinity due to slower, controlled reduction kinetics, leading to enhanced stability and bioactivity over chemical variants. This supports our results, suggesting the Persian lime extract yields AgNPs with structural advantages for urease inhibition52,53. UV-vis analysis UV-Vis spectroscopy was employed to verify the formation and assess the stability of both chemically synthesized (AgNPs_Chem) and green-synthesized (AgNPs_Citrus) silver nanoparticles (Fig. 5). As shown in Fig. 5b, both samples exhibited a characteristic surface plasmon resonance (SPR) band in the range of 418–435 nm, confirming successful nanoparticle synthesis54,55. A distinct difference was observed in the spectral profiles: AgNPs_Citrus (sample 7) exhibited a sharp peak at 418 nm, consistent with spherical nanoparticles of uniform size. In contrast, the SPR signal for AgNPs_Chem (sample 10) was broader and red shifted to 432 nm, suggesting a more polydisperse population. This 14 nm blueshift in the AgNPs_Citrus spectrum is indicative of smaller particle dimensions, as the SPR wavelength scales with diameter. The observed shift and peak sharpness collectively validate the nanoscale formation of silver and highlight the influence of synthesis route on particle size and monodispersity, with the green synthesis likely leveraging phytochemical capping agents from the citrus extract to modulate nucleation and growth. UV-Vis spectrum of silver nanoparticles displaying surface plasmon resonance peak (a) synthesized by green (1 to 9) and chemical (10) methods, (b) for samples (7) and (10). Comparative literature shows similar SPR peaks around 410–430 nm for citrus-extract AgNPs, such as those from Citrus limon zest at ~ 420 nm, validating our synthesis. Green-synthesized AgNPs typically exhibit narrower, blue-shifted peaks compared to chemical ones, as seen in a study where plant-extract AgNPs had superior optical properties and bioactivity due to organic capping. This comparison indicates our green AgNPs are better suited for applications requiring high surface plasmon activity, such as antimicrobial sensing or enzyme inhibition43,56. Collectively, the FT-IR, DLS, TEM, XRD, and UV-Vis analyses provide convergent evidence for the successful green synthesis of AgNPs, confirming phytochemical-mediated reduction and capping (FT-IR), small hydrodynamic size and colloidal stability (DLS, zeta potential), spherical morphology with minimal aggregation (TEM), high crystalline purity (XRD), and characteristic plasmonic properties consistent with uniform, nanoscale silver particles (UV-Vis). Taguchi optimization results The Taguchi L9 array (Table 1) yielded particle sizes from 44.62 nm (sample 7) to 530 nm (sample 1). Main effects plot (Fig. 6a) showed temperature as the most influential factor (steepest slope), followed by extract concentration, volume, and pH. S/N ratio analysis (smaller is better, Fig. 6b) confirmed optimal conditions: pH 5, extract volume 2500 µL, concentration 5 mM, temperature 80 °C, with predicted size 40.5 nm. Delta values ranked factors: temperature (9.70), concentration (8.14), volume (5.35), pH (4.06). Higher temperature accelerates reduction kinetics, promoting nucleation over growth. Increased concentration provides more reductants, yielding smaller particles. Optimal volume balances reductant availability without dilution effects. Acidic pH enhances polyphenol reactivity, as protonation facilitates electron transfer. These results align with literature, where elevated temperature and reductant concentration minimize size in green synthesis. The dominant role of temperature in controlling nanoparticle size can be attributed to its direct effect on reaction kinetics: elevated temperatures increase the rate of Ag+ ion reduction, favoring rapid nucleation over prolonged crystal growth, consistent with classical nucleation theory57. Similarly, higher extract concentrations provide a surplus of biomolecular reducing agents, accelerating nucleation and enhancing colloidal stabilization through effective capping. The moderate influence of extract volume reflects a trade-off between adequate phytochemical supply and reactant dilution, while the relatively lower impact of pH suggests that the protonation-driven enhancement of polyphenol reactivity, although beneficial at acidic conditions, plays a secondary role compared to thermal and concentration-driven kinetics58,59. The Taguchi optimization effectively minimized particle size by identifying key parameter interactions, with temperature’s dominance reflecting its role in kinetic control. The predicted size of 40.5 nm demonstrates the method’s robustness. In comparison, other studies using Taguchi for green AgNPs synthesis, such as with Athyrium filix femina extract, found temperature and concentration as top factors, yielding sizes around 30–50 nm under similar conditions. A guava extract study optimized to ~ 44 nm, confirming that acidic pH and high temperature favor smaller particles in plant-based syntheses, often outperforming non-optimized methods by 20–30% in size reduction. This validates our approach as efficient for scalable, eco-friendly production57,60. While the S/N analysis predicts an optimal combination of pH 5, 2500 µL, 5 mM, and 80 °C (predicted size ~ 40.5 nm), Sample 7 (3500 µL) was selected as the practical optimum based on its experimentally verified smallest size within the L9 array. (a) Minitab software response according to the effect of various factors on the size of nanoparticles, (b) Minitab Software Signal-to-Noise Ratio Response. Urease inhibition activity Green synthesized AgNPs (AgNPs_Citrus) exhibited potent urease inhibition with an IC₅₀ of 15.02 ± 2.36 µg/mL, significantly lower than the Persian lime extract alone (IC₅₀ = 33.31 ± 1.43 µg/mL, p = 0.0078, Tukey’s HSD), confirming that the enhanced activity is not solely due to residual phytochemicals but arises from a synergistic effect of the phytochemical corona and the AgNP core. In contrast, chemically synthesized AgNPs (citrate-capped, Frens method) exhibited only 23% inhibition at 100 µg/mL (p < 0.001 vs. green AgNPs, Tukey’s HSD), demonstrating that silver nanoparticles without bioactive capping have minimal urease inhibitory activity. This marked difference in activity suggests that the organic capping layer derived from Persian lime extract and the smaller particle size of green-synthesized AgNPs facilitate more effective enzyme interaction compared to citrate-capped chemical AgNPs, though the absence of full dose–response data for chemical AgNPs limits direct IC50 comparison. The minimal urease inhibitory activity of chemically synthesized AgNPs can be attributed to their citrate-only surface chemistry, which lacks the bioactive phytochemical corona present on green AgNPs. Without the synergistic contributions of plant-derived flavonoids, polyphenols, and organic acids — which facilitate specific enzyme binding and enhance multi-modal inhibition — citrate-capped AgNPs exhibit only non-specific, weak interactions with the urease enzyme, resulting in inhibition below 50% even at the highest tested concentration. Dose-response curves (Fig. 7; Table 2) showed concentration-dependent inhibition, with 62%, and 78% at 100 µg/mL for crude extract and AgNPs_Citrus respectively, but chemical synthesized AgNPs exhibited only 23% inhibition activity in the same concentration. Dose-response curve for urease inhibition by (a) Persian lime (Citrus latifolia) extract, (b) green synthesized AgNPs, showing IC50 calculation. Chemical AgNPs are not included due to insufficient inhibitory activity (< 50% at 100 µg/mL) for reliable nonlinear regression curve fitting. Error bars represent SD (n = 3 independent assays). Table 2Inhibitory activity of chemical synthesized AgNPs, green synthesized, and Persian lime (Citrus latifolia) extract against urease.SampleInhibition (%) (mean ± SD)IC50 (µg/mL) (mean ± SD) R 2 GroupGreen synthesized AgNPs78 ± 3.215.02 ± 2.360.98aPersian lime extract62 ± 2.833.31 ± 1.430.97bChemical synthesized AgNPs23 ± 4.1N.D. *—c*Different superscript letters (a, b, c) indicate statistically significant differences (p < 0.05, Tukey’s HSD). All values are mean ± SD, n = 3 independent assays. ND = Not determined; a full dose–response curve could not be obtained because inhibition did not reach 50% at the highest tested concentration (100 µg/mL), precluding reliable IC50 calculation via nonlinear regression. Inhibitory activity of chemical synthesized AgNPs, green synthesized, and Persian lime (Citrus latifolia) extract against urease. *Different superscript letters (a, b, c) indicate statistically significant differences (p < 0.05, Tukey’s HSD). All values are mean ± SD, n = 3 independent assays. ND = Not determined; a full dose–response curve could not be obtained because inhibition did not reach 50% at the highest tested concentration (100 µg/mL), precluding reliable IC50 calculation via nonlinear regression. The enhanced activity is attributed to smaller size and organic capping, facilitating enzyme binding. AgNPs may chelate nickel ions in the urease active site or induce conformational changes, though these mechanisms were not directly investigated in the present study and remain hypothetical based on literature precedents61. Synergistic effects from extract bioactive compounds further boost inhibition. Time-dependent studies (30 min optimal) and pH stability (pH 7.4) confirm practical applicability. Compared to standard inhibitors like acetohydroxamic acid (IC50 ~50 µM), AgNPs offer lower effective concentrations, highlighting their potential. AgNPs_Chem with citrate capping exhibited substantially lower inhibitory activity (23% at 100 µg/mL), likely due to less specific interactions with the enzyme active site and differences in surface chemistry compared to the polyphenol-rich capping of green-synthesized AgNPs. However, since IC50 could not be determined for chemical AgNPs, a quantitative comparison of inhibitory potency between the two formulations is not possible62. The smaller size of green NPs increases surface area, enhancing contact with enzyme63. The urease inhibition results demonstrate a clear dose-response relationship, with AgNPs_Citrus achieving full inhibition at higher concentrations. Based on literature reports of AgNP antimicrobial and enzyme inhibitory mechanisms, the observed activity could involve multi-modal actions such as ROS generation, metal chelation, and/or physical interaction with the enzyme active site64,65. However, direct experimental confirmation of these mechanisms (e.g., ROS quantification, nickel ion displacement assays, or structural studies) was not performed and is recommended for future work. This IC50 of 15.02 ± 2.36 µg/mL is notably low, indicating high potency. Comparative studies report similar or higher IC50 values for green AgNPs; for instance, Solanum xanthocarpum berry extract AgNPs showed effective urease inhibition against H. pylori with IC50 around 10–20 µg/mL. Quercetin-conjugated AgNPs exhibited enhanced inhibition with IC50 values about 0.473 µg/mL range, attributing synergy to organic components, much like our Persian lime capping. Green AgNPs have been reported to exhibit enhanced bioactivity compared to chemically synthesized counterparts in several studies, such as Ricinus communis-derived AgNPs showing 83% inhibition at low doses. While our data show markedly higher inhibitory activity for green-synthesized AgNPs at 100 µg/mL (78% vs. 23%), the absence of full dose–response data for chemical AgNPs limits direct IC50 comparison. Nonetheless, these results, combined with the favorable physicochemical properties of AgNPs_Citrus, provide a strong rationale for further development as urease inhibitors with potential relevance to H. pylori-associated pathogenesis46,66,67. It is worth noting that conventional first-line antibiotics against H. pylori (e.g., clarithromycin, amoxicillin, metronidazole) primarily target bacterial viability through mechanisms distinct from urease inhibition, making direct IC50 comparisons methodologically inappropriate. However, the rising resistance rates to these antibiotics — exceeding 30% for clarithromycin and 40% for metronidazole in many regions5,8— underscore the need for complementary strategies such as urease-targeted nanotherapeutics. The potent urease inhibition demonstrated by our green AgNPs (IC50=15.02 ± 2.36 µg/mL), which surpasses the standard inhibitor acetohydroxamic acid (IC50∼50 µM) and significantly outperforms chemically synthesized AgNPs, positions this nanosystem as a promising adjunct to existing antibiotic regimens or as a standalone alternative in resistance-prevalent settings. The combined action of nickel chelation, ROS generation, induction of conformational changes, and enhanced active-site interaction facilitated by the small particle size and phytochemical capping agents collectively accounts for the potent, dose-dependent urease inhibition observed with our green-synthesized AgNPs. It is important to note that the urease inhibition reported herein was assessed using jack bean urease, a standard model enzyme widely employed in urease inhibitor screening due to its structural and catalytic similarity to bacterial ureases, including that of H. pylori. While our findings demonstrate potent urease inhibitory activity, translation to effective H. pylori inhibition requires additional validation. Urease is essential for bacterial survival in gastric acid; however, H. pylori pathogenesis involves multiple virulence factors including adhesins, cytotoxins, motility, and biofilm formation. Therefore, urease inhibition alone may not fully eradicate infection. Future studies should evaluate minimum inhibitory concentration (MIC), bactericidal activity, biofilm disruption, stability in simulated gastric fluid, and in vivo efficacy in infected animal models. While this study demonstrates the feasibility of green AgNP synthesis using C. aurantium peel extract, several challenges must be addressed for industrial or clinical scale-up: (i) batch-to-batch reproducibility requires standardization of plant material and extract preparation; (ii) production efficiency and cost-effectiveness need evaluation in continuous-flow or large-batch reactors; (iii) purification and quality control protocols must be developed for scalable separation and characterization; (iv) stability and shelf life require systematic assessment under storage conditions; (v) regulatory compliance demands GMP validation, comprehensive toxicological data, and demonstration of clinical safety; and (vi) sterilization compatibility must be established without compromising nanoparticle properties. These considerations represent important areas for future development toward translational applications. Conclusion and future perspectives The present study investigated the green synthesis of silver nanoparticles (AgNPs) using dried Persian lime (Citrus latifolia) extract as a dual bio-reducing and stabilizing agent, with the aim of developing an eco-friendly urease inhibitor to address the growing challenge of antibiotic-resistant Helicobacter pylori infections. H. pylori, a primary causative agent of gastric disorders including peptic ulcers and gastric carcinoma, relies on its urease enzyme to neutralize stomach acidity and sustain colonization, making urease a critical therapeutic target. The synthesis parameters — including pH, extract volume, extract concentration, and reaction temperature — were systematically optimized using the Taguchi experimental design to minimize particle size. The optimized green-synthesized AgNPs exhibited a mean particle size of 27.63 nm, spherical morphology, and a zeta potential of − 13.8 mV, indicating moderate colloidal stability. The physicochemical characteristics were thoroughly confirmed through multiple analytical techniques, including FT-IR spectroscopy (functional group identification and capping agent verification), DLS (hydrodynamic size distribution), TEM (morphology and core size), XRD (crystalline structure), and UV-Vis spectroscopy (surface plasmon resonance). Among the four synthesis parameters evaluated, temperature was identified as the most influential factor governing particle size, consistent with reported findings in the green synthesis literature. Urease inhibition assays based on the Berthelot method demonstrated that the green-synthesized AgNPs possessed markedly higher inhibitory activity, with an IC50 of 15.02 ± 2.36 µg/mL, compared to the Persian lime extract alone (IC50​=33.31 ± 1.43 µg/mL). Notably, chemically synthesized AgNPs failed to reach 50% inhibition at the tested concentrations, and therefore their IC50 ​ could not be determined. This disparity suggests that the enhanced performance of green AgNPs may be attributed to the synergistic interplay between their smaller nanoparticle size and the bioactive phytochemical capping agents derived from the Citrus latifolia extract. Based on our characterization and literature precedent, we propose several potential mechanisms that warrant further investigation: (i) nickel chelation by hydroxyl- and carboxyl-rich phytochemicals on AgNP surfaces, supported by FT-IR confirmation of these functional groups but requiring direct chelation assays for validation; (ii) ROS generation by AgNPs, a well-documented phenomenon in the literature but not directly measured in this study; and (iii) structural disruption of urease through nanoparticle-protein interactions, inferred from dose-dependent inhibition kinetics but requiring spectroscopic or computational validation. These mechanisms remain hypothetical and require targeted mechanistic studies including metal chelation assays, ROS quantification, and enzyme conformational analysis. From a practical standpoint, the green synthesis approach demonstrated in this work offers notable advantages over conventional chemical reduction methods, including reduced environmental impact, avoidance of hazardous chemical reagents, and the utilization of abundant, renewable citrus resources — factors that may support future scalability. The involvement of plant-derived biomolecules as capping agents may also contribute to potential biocompatibility, though this remains to be confirmed through dedicated cytotoxicity and biocompatibility assays. Nevertheless, several limitations should be acknowledged. The current findings are based entirely on in vitro urease inhibition data, and no in vivo studies were conducted to evaluate the pharmacokinetics, systemic safety, or therapeutic efficacy of the synthesized AgNPs. Additionally, the precise molecular mechanisms underlying urease inhibition were not experimentally elucidated in this study and remain hypothetical. Future research should therefore focus on in vivo validation, detailed mechanistic studies (e.g., molecular docking, enzyme kinetics), and the development of potential delivery systems such as oral formulations. Overall, the results of this study suggest that bio-synthesized AgNPs using Citrus latifolia extract may serve as a promising candidate for the development of eco-friendly, plant-based urease inhibitors. By integrating traditional herbal resources with modern nanotechnology, this work represents a promising step toward sustainable nanomedicine strategies, potentially contributing to future efforts in mitigating urease-mediated pathogenesis associated with H. pylori infections. Acknowledgements This work was supported by the Deputy of Research of Zanjan University of Medical Sciences [A-12-1510-14, ethical code: IR.ZUMS.BLC.1403.068]. Author contributions Reza Ghanbari: Conducted the experiments, performed data analysis, and wrote the original draft of the manuscript. Alireza Yazdinezhad: Designed the project and reviewed the manuscript. Hossein Danafar: Designed the project, contributed to data analysis, and reviewed and edited the manuscript. Shayan Asadi: Performed optimized synthesis parameters. Hafezeh Salehabadi: Supervised the project, designed the study, and reviewed and revised the manuscript. All authors have read and approved the final version of the manuscript. Data availability The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request, as the authors obtained all the data analyzed. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request, as the authors obtained all the data analyzed.